Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fatty Acid Desaturases | 10 | 2020 | 48 | 1.970 |
Why?
|
| gamma-Linolenic Acid | 3 | 2020 | 9 | 1.380 |
Why?
|
| Linoleic Acid | 5 | 2020 | 16 | 1.040 |
Why?
|
| Neutrophils | 4 | 2014 | 106 | 0.830 |
Why?
|
| Plant Oils | 2 | 2020 | 17 | 0.830 |
Why?
|
| Lipids | 5 | 2020 | 229 | 0.760 |
Why?
|
| Phospholipids | 2 | 2014 | 28 | 0.750 |
Why?
|
| Soybean Oil | 1 | 2020 | 7 | 0.720 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2020 | 1062 | 0.700 |
Why?
|
| Multigene Family | 7 | 2017 | 51 | 0.670 |
Why?
|
| Eicosanoids | 2 | 2016 | 8 | 0.670 |
Why?
|
| Arachidonic Acid | 5 | 2015 | 35 | 0.610 |
Why?
|
| Fatty Acids | 2 | 2015 | 98 | 0.590 |
Why?
|
| Fatty Acids, Omega-6 | 6 | 2017 | 29 | 0.510 |
Why?
|
| Fish Oils | 2 | 2014 | 43 | 0.490 |
Why?
|
| Fatty Acids, Unsaturated | 5 | 2020 | 37 | 0.490 |
Why?
|
| Inflammation | 4 | 2017 | 530 | 0.490 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 104 | 0.440 |
Why?
|
| DNA Methylation | 3 | 2018 | 140 | 0.390 |
Why?
|
| European Continental Ancestry Group | 7 | 2020 | 1167 | 0.380 |
Why?
|
| Dietary Supplements | 4 | 2017 | 188 | 0.380 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2011 | 31 | 0.380 |
Why?
|
| Diastole | 1 | 2011 | 96 | 0.370 |
Why?
|
| Memory | 1 | 2011 | 190 | 0.330 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 4 | 2020 | 13 | 0.330 |
Why?
|
| Fatty Acids, Omega-3 | 4 | 2017 | 56 | 0.290 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2007 | 24 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2014 | 1428 | 0.280 |
Why?
|
| Humans | 23 | 2020 | 31981 | 0.260 |
Why?
|
| Aging | 1 | 2011 | 945 | 0.240 |
Why?
|
| African Americans | 5 | 2017 | 1427 | 0.230 |
Why?
|
| Cholesterol | 3 | 2015 | 251 | 0.230 |
Why?
|
| Brain | 1 | 2011 | 950 | 0.230 |
Why?
|
| Middle Aged | 10 | 2020 | 11845 | 0.220 |
Why?
|
| Male | 11 | 2020 | 19161 | 0.210 |
Why?
|
| Animals | 9 | 2016 | 7463 | 0.200 |
Why?
|
| Aged | 7 | 2020 | 10332 | 0.200 |
Why?
|
| Group IV Phospholipases A2 | 2 | 2014 | 4 | 0.200 |
Why?
|
| Adult | 8 | 2020 | 9340 | 0.190 |
Why?
|
| Genotype | 2 | 2020 | 733 | 0.190 |
Why?
|
| Phospholipase D | 2 | 2014 | 4 | 0.190 |
Why?
|
| Chromatography, Thin Layer | 2 | 2014 | 8 | 0.190 |
Why?
|
| Type C Phospholipases | 2 | 2014 | 7 | 0.190 |
Why?
|
| Female | 11 | 2020 | 19920 | 0.180 |
Why?
|
| Double-Blind Method | 1 | 2020 | 525 | 0.160 |
Why?
|
| Saliva | 1 | 2018 | 36 | 0.150 |
Why?
|
| Leukocytes | 1 | 2018 | 57 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 55 | 0.150 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2017 | 24 | 0.150 |
Why?
|
| Mutation | 3 | 2009 | 488 | 0.150 |
Why?
|
| Young Adult | 3 | 2020 | 2607 | 0.150 |
Why?
|
| Cholesterol, HDL | 2 | 2015 | 177 | 0.150 |
Why?
|
| Gene Frequency | 3 | 2012 | 220 | 0.140 |
Why?
|
| Stearic Acids | 1 | 2015 | 5 | 0.130 |
Why?
|
| Docosahexaenoic Acids | 1 | 2015 | 21 | 0.130 |
Why?
|
| Temporal Lobe | 1 | 2015 | 30 | 0.130 |
Why?
|
| Cohort Studies | 1 | 2020 | 1821 | 0.130 |
Why?
|
| Diet | 2 | 2017 | 386 | 0.130 |
Why?
|
| Liver | 2 | 2015 | 483 | 0.130 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 104 | 0.130 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2013 | 29 | 0.130 |
Why?
|
| Corn Oil | 1 | 2014 | 3 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2016 | 244 | 0.120 |
Why?
|
| Linkage Disequilibrium | 2 | 2014 | 185 | 0.120 |
Why?
|
| United States | 2 | 2015 | 3936 | 0.120 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 173 | 0.120 |
Why?
|
| Triglycerides | 1 | 2015 | 230 | 0.120 |
Why?
|
| Stearoyl-CoA Desaturase | 2 | 2011 | 14 | 0.120 |
Why?
|
| Body Mass Index | 2 | 2015 | 922 | 0.120 |
Why?
|
| Prospective Studies | 1 | 2020 | 2282 | 0.120 |
Why?
|
| Leukotrienes | 1 | 2013 | 3 | 0.120 |
Why?
|
| Echium | 1 | 2013 | 11 | 0.110 |
Why?
|
| Enzyme Activation | 1 | 2014 | 135 | 0.110 |
Why?
|
| Overweight | 1 | 2015 | 279 | 0.110 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 34 | 0.110 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 57 | 0.100 |
Why?
|
| Body Weight | 2 | 2011 | 310 | 0.100 |
Why?
|
| Phagocytosis | 1 | 2011 | 14 | 0.100 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2011 | 11 | 0.100 |
Why?
|
| Pseudomonas Infections | 1 | 2011 | 14 | 0.100 |
Why?
|
| Siblings | 1 | 2011 | 25 | 0.100 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2011 | 35 | 0.100 |
Why?
|
| alpha-Linolenic Acid | 3 | 2017 | 11 | 0.100 |
Why?
|
| Encephalitis | 1 | 2011 | 4 | 0.100 |
Why?
|
| Family Health | 1 | 2011 | 76 | 0.100 |
Why?
|
| Cell Count | 1 | 2011 | 47 | 0.100 |
Why?
|
| African Continental Ancestry Group | 1 | 2012 | 363 | 0.100 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 146 | 0.090 |
Why?
|
| Asthma | 1 | 2013 | 259 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 470 | 0.090 |
Why?
|
| Vision, Ocular | 1 | 2011 | 33 | 0.090 |
Why?
|
| Organ Size | 1 | 2011 | 210 | 0.090 |
Why?
|
| Geography | 1 | 2010 | 34 | 0.090 |
Why?
|
| Risk Factors | 2 | 2015 | 3867 | 0.090 |
Why?
|
| Genetics, Population | 1 | 2010 | 32 | 0.090 |
Why?
|
| Community Health Services | 1 | 2010 | 56 | 0.090 |
Why?
|
| Threonine | 1 | 2009 | 9 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2014 | 682 | 0.090 |
Why?
|
| Dietary Fats | 1 | 2010 | 111 | 0.090 |
Why?
|
| Hippocampus | 1 | 2011 | 171 | 0.090 |
Why?
|
| Diet, Reducing | 1 | 2010 | 106 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 532 | 0.080 |
Why?
|
| X Chromosome Inactivation | 1 | 2008 | 6 | 0.080 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2008 | 6 | 0.080 |
Why?
|
| Phosphatidylinositols | 1 | 2008 | 2 | 0.080 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2008 | 7 | 0.080 |
Why?
|
| Motor Activity | 1 | 2011 | 325 | 0.080 |
Why?
|
| Luminescent Proteins | 1 | 2008 | 26 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 2008 | 101 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 48 | 0.080 |
Why?
|
| Health Promotion | 1 | 2010 | 246 | 0.080 |
Why?
|
| Exercise Therapy | 1 | 2010 | 270 | 0.070 |
Why?
|
| Depression | 1 | 2011 | 443 | 0.070 |
Why?
|
| Phospholipases A2 | 1 | 2007 | 20 | 0.070 |
Why?
|
| Rats | 1 | 2011 | 1596 | 0.070 |
Why?
|
| Cognition | 1 | 2011 | 553 | 0.070 |
Why?
|
| Alleles | 2 | 2018 | 248 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2018 | 24 | 0.060 |
Why?
|
| Models, Biological | 1 | 2007 | 391 | 0.060 |
Why?
|
| Obesity | 1 | 2010 | 1176 | 0.050 |
Why?
|
| Reactive Oxygen Species | 2 | 2011 | 157 | 0.040 |
Why?
|
| Protein Binding | 2 | 2009 | 201 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 1017 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2018 | 80 | 0.040 |
Why?
|
| CpG Islands | 1 | 2017 | 45 | 0.040 |
Why?
|
| Demography | 1 | 2017 | 109 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 137 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2017 | 75 | 0.040 |
Why?
|
| Sexual Maturation | 1 | 2015 | 25 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2014 | 3315 | 0.030 |
Why?
|
| Leukotriene B4 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 19 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2014 | 203 | 0.030 |
Why?
|
| Seeds | 1 | 2013 | 10 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 104 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 56 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2014 | 122 | 0.030 |
Why?
|
| Adolescent | 2 | 2013 | 3515 | 0.030 |
Why?
|
| Africa | 1 | 2012 | 27 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2014 | 492 | 0.030 |
Why?
|
| Complement C5 | 1 | 2011 | 1 | 0.030 |
Why?
|
| Complement C7 | 1 | 2011 | 1 | 0.030 |
Why?
|
| Opsonin Proteins | 1 | 2011 | 4 | 0.030 |
Why?
|
| Complement C3 | 1 | 2011 | 9 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 2011 | 23 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 833 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 108 | 0.020 |
Why?
|
| Protestantism | 1 | 2010 | 7 | 0.020 |
Why?
|
| Directive Counseling | 1 | 2010 | 18 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2010 | 61 | 0.020 |
Why?
|
| Lipoylation | 1 | 2009 | 3 | 0.020 |
Why?
|
| Respiratory Burst | 1 | 2009 | 3 | 0.020 |
Why?
|
| Cricetulus | 1 | 2009 | 12 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2009 | 8 | 0.020 |
Why?
|
| CHO Cells | 1 | 2009 | 24 | 0.020 |
Why?
|
| Cricetinae | 1 | 2009 | 39 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2009 | 31 | 0.020 |
Why?
|
| Lung | 1 | 2011 | 245 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2011 | 397 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2011 | 250 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 228 | 0.020 |
Why?
|
| Cytochrome b Group | 1 | 2008 | 2 | 0.020 |
Why?
|
| Introns | 1 | 2008 | 39 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2008 | 7 | 0.020 |
Why?
|
| src Homology Domains | 1 | 2008 | 13 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2008 | 30 | 0.020 |
Why?
|
| Glycine | 1 | 2008 | 27 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2008 | 70 | 0.020 |
Why?
|
| Liposomes | 1 | 2008 | 27 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 99 | 0.020 |
Why?
|
| Organelles | 1 | 2008 | 2 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 2008 | 8 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2008 | 82 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 74 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 65 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 283 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 356 | 0.020 |
Why?
|
| Cell Line | 1 | 2008 | 435 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 1125 | 0.020 |
Why?
|
| Calcium | 1 | 2008 | 307 | 0.020 |
Why?
|
| Mice | 1 | 2011 | 2472 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 2151 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 2280 | 0.020 |
Why?
|